ZA201003718B - Stable crystalline salt of (r)-3-flurirphenyl-3,4,5-trifluorobenzylcaramic acid 1-azabicyclo [2.2.2] oct-3-yl ester - Google Patents
Stable crystalline salt of (r)-3-flurirphenyl-3,4,5-trifluorobenzylcaramic acid 1-azabicyclo [2.2.2] oct-3-yl esterInfo
- Publication number
- ZA201003718B ZA201003718B ZA2010/03718A ZA201003718A ZA201003718B ZA 201003718 B ZA201003718 B ZA 201003718B ZA 2010/03718 A ZA2010/03718 A ZA 2010/03718A ZA 201003718 A ZA201003718 A ZA 201003718A ZA 201003718 B ZA201003718 B ZA 201003718B
- Authority
- ZA
- South Africa
- Prior art keywords
- trifluorobenzylcaramic
- flurirphenyl
- azabicyclo
- oct
- ester
- Prior art date
Links
- -1 1-azabicyclo [2.2.2] oct-3-yl Chemical group 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07384038A EP2065385A1 (en) | 2007-11-28 | 2007-11-28 | Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester |
| PCT/EP2008/010012 WO2009068253A2 (en) | 2007-11-28 | 2008-11-26 | Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201003718B true ZA201003718B (en) | 2011-08-31 |
Family
ID=39401152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2010/03718A ZA201003718B (en) | 2007-11-28 | 2010-05-25 | Stable crystalline salt of (r)-3-flurirphenyl-3,4,5-trifluorobenzylcaramic acid 1-azabicyclo [2.2.2] oct-3-yl ester |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8492402B2 (enExample) |
| EP (2) | EP2065385A1 (enExample) |
| JP (1) | JP5336509B2 (enExample) |
| KR (1) | KR101557832B1 (enExample) |
| CN (1) | CN101925600B (enExample) |
| AU (1) | AU2008329181B2 (enExample) |
| BR (1) | BRPI0819607A2 (enExample) |
| CA (1) | CA2706565C (enExample) |
| DK (1) | DK2220082T3 (enExample) |
| EA (1) | EA017483B1 (enExample) |
| ES (1) | ES2498819T3 (enExample) |
| IL (1) | IL206032A (enExample) |
| MX (1) | MX2010005850A (enExample) |
| NZ (1) | NZ585833A (enExample) |
| PL (1) | PL2220082T3 (enExample) |
| UA (1) | UA102083C2 (enExample) |
| WO (1) | WO2009068253A2 (enExample) |
| ZA (1) | ZA201003718B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002228015B2 (en) | 2000-12-22 | 2007-08-23 | Almirall, S.A. | Quinuclidine carbamate derivatives and their use as M3 antagonists |
| JP5745283B2 (ja) † | 2010-02-12 | 2015-07-08 | ファイザー・インク | ８−フルオロ−２−｛４−［（メチルアミノ）メチル］フェニル｝−１，３，４，５−テトラヒドロ−６Ｈ−アゼピノ［５，４，３−ｃｄ］インドール−６−オンの塩および多形体 |
| KR101978364B1 (ko) | 2017-06-15 | 2019-05-14 | 크리스탈지노믹스(주) | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법 |
| KR102678356B1 (ko) * | 2018-10-29 | 2024-06-26 | 씨지인바이츠 주식회사 | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 인산염, 타르타르산염 또는 이들의 조합을 포함하는 약제학적 조성물 및 그 제조방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE510305C2 (sv) * | 1997-05-30 | 1999-05-10 | Astra Ab | Nytt salt |
| IL153707A0 (en) * | 2000-06-27 | 2003-07-06 | S A L V A T Lab Sa | Carbamates derived from arylalkylamines |
| AU2002228015B2 (en) * | 2000-12-22 | 2007-08-23 | Almirall, S.A. | Quinuclidine carbamate derivatives and their use as M3 antagonists |
| EA006505B1 (ru) * | 2001-12-20 | 2005-12-29 | Лабораториос С.А.Л.В.А.Т.,С.А. | Производные карбамата 1-алкил-1-азониабицикло[2.2.2]октана и их применение в качестве антагонистов мускаринового рецептора |
| ES2203327B1 (es) * | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen. |
| ES2246170B1 (es) * | 2004-07-29 | 2007-04-01 | Almirall Prodesfarma, S.A. | Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio. |
-
2007
- 2007-11-28 EP EP07384038A patent/EP2065385A1/en not_active Withdrawn
-
2008
- 2008-11-26 WO PCT/EP2008/010012 patent/WO2009068253A2/en not_active Ceased
- 2008-11-26 EA EA201070651A patent/EA017483B1/ru not_active IP Right Cessation
- 2008-11-26 DK DK08854867.2T patent/DK2220082T3/da active
- 2008-11-26 PL PL08854867T patent/PL2220082T3/pl unknown
- 2008-11-26 MX MX2010005850A patent/MX2010005850A/es active IP Right Grant
- 2008-11-26 CA CA2706565A patent/CA2706565C/en not_active Expired - Fee Related
- 2008-11-26 ES ES08854867.2T patent/ES2498819T3/es active Active
- 2008-11-26 UA UAA201007997A patent/UA102083C2/uk unknown
- 2008-11-26 NZ NZ585833A patent/NZ585833A/en not_active IP Right Cessation
- 2008-11-26 EP EP08854867.2A patent/EP2220082B1/en not_active Not-in-force
- 2008-11-26 CN CN2008801254506A patent/CN101925600B/zh not_active Expired - Fee Related
- 2008-11-26 US US12/744,493 patent/US8492402B2/en not_active Expired - Fee Related
- 2008-11-26 AU AU2008329181A patent/AU2008329181B2/en not_active Ceased
- 2008-11-26 BR BRPI0819607A patent/BRPI0819607A2/pt not_active IP Right Cessation
- 2008-11-26 JP JP2010535281A patent/JP5336509B2/ja not_active Expired - Fee Related
- 2008-11-28 KR KR1020107013939A patent/KR101557832B1/ko not_active Expired - Fee Related
-
2010
- 2010-05-25 ZA ZA2010/03718A patent/ZA201003718B/en unknown
- 2010-05-27 IL IL206032A patent/IL206032A/en not_active IP Right Cessation
-
2013
- 2013-02-08 US US13/763,063 patent/US8871787B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2220082B1 (en) | 2014-06-25 |
| MX2010005850A (es) | 2010-09-03 |
| ES2498819T3 (es) | 2014-09-25 |
| KR101557832B1 (ko) | 2015-10-06 |
| DK2220082T3 (da) | 2014-10-06 |
| NZ585833A (en) | 2011-05-27 |
| JP2011504890A (ja) | 2011-02-17 |
| EP2220082A2 (en) | 2010-08-25 |
| HK1144192A1 (en) | 2011-02-02 |
| EA201070651A1 (ru) | 2010-12-30 |
| AU2008329181A1 (en) | 2009-06-04 |
| US20110207769A1 (en) | 2011-08-25 |
| WO2009068253A2 (en) | 2009-06-04 |
| US8871787B2 (en) | 2014-10-28 |
| CA2706565C (en) | 2015-04-28 |
| PL2220082T3 (pl) | 2014-12-31 |
| CN101925600A (zh) | 2010-12-22 |
| CA2706565A1 (en) | 2009-06-04 |
| KR20100103532A (ko) | 2010-09-27 |
| AU2008329181B2 (en) | 2012-03-29 |
| BRPI0819607A2 (pt) | 2015-10-13 |
| WO2009068253A3 (en) | 2009-08-13 |
| JP5336509B2 (ja) | 2013-11-06 |
| UA102083C2 (uk) | 2013-06-10 |
| EP2065385A1 (en) | 2009-06-03 |
| IL206032A (en) | 2014-07-31 |
| US20140051721A1 (en) | 2014-02-20 |
| IL206032A0 (en) | 2010-11-30 |
| EA017483B1 (ru) | 2012-12-28 |
| CN101925600B (zh) | 2013-01-09 |
| US8492402B2 (en) | 2013-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2350075T3 (pl) | Podstawione związki imidazo[1,2b]pirydazynowe jako inhibitory kinaz Trk | |
| EG25765A (en) | Pyrido [2,3-B] pyrazine derivatives useful as herbicidal compounds | |
| IL244239B (en) | Process for the preparation of (s2,r5)-6-(benzyl/allyl)oxy-7-oxo-6,1-diazabicyclo[1.2.3]octane-2-carboxylic acid, and also its esters and salts | |
| WO2008128028A3 (en) | Solifenacin compositions | |
| ZA200903030B (en) | Methods,compounds,compositions and vehicles for delivering 3-amino-1-propanesulfonic acid | |
| WO2008155615A3 (en) | An improved process for the preparation of cephalosporin antibiotic | |
| ZA201100437B (en) | 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazine derivatives as met kinase inhibitors | |
| ZA200905832B (en) | Crystalline forms of an 8-azabicyclo [3.2.1] octane compound | |
| ZA201107412B (en) | Methods for the preparation of [2-8,9-dioxo2,6-diazabicyclo[5.2.0]non-1(1)-en-2-yl)ethyl]phosphonic acid and precursors thereof | |
| ZA201003718B (en) | Stable crystalline salt of (r)-3-flurirphenyl-3,4,5-trifluorobenzylcaramic acid 1-azabicyclo [2.2.2] oct-3-yl ester | |
| WO2009037538A3 (en) | Process for the preparation of lamivudine form i | |
| WO2009122429A3 (en) | Crystalline oxybutynin and process for preparing the same | |
| EP2077994A4 (en) | CRYSTALLINE WATER-FREE S - (-) - AMLODIPINADIPINIC ACID SALT AND METHOD FOR THE PRODUCTION THEREOF | |
| WO2007013043A3 (en) | Processes for the preparation of 7-amino-3-vinyl cephalosporanic acid | |
| WO2011058521A3 (en) | Process for the preparation of crystalline form i of l-malic acid salt of sunitinib | |
| IL187660A0 (en) | Process for the preparation of sulfonic acid salts of oxabispidines | |
| PL2081934T3 (pl) | Proces wytwarzania krystalicznej pirazolo[1,5-a] pirymidyny | |
| HK1186467A (en) | Process for the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives | |
| HK1139160A (en) | Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan | |
| HK1118277A (en) | Process for the preparation of sulfonic acid salts of oxabispidines | |
| HK1171733A (en) | Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid | |
| AU2007905798A0 (en) | alpha-Cyclopropyl-alpha-Amino Carboxylic Acid Compounds and Methods for their Preparation | |
| HK1163072A (zh) | 5，7-二氫-6h-嘧啶並[5，4-d][1]苯並氮雜卓-6-硫酮作為plk抑制劑 | |
| HK1143585A (en) | 6-substituted sulfonyl azabicycloý3.2.1"octanes useful to inhibit 11-hydroxysteroid dehydrogenase type-1 | |
| AU2007904276A0 (en) | Acid sulphate soil treatment |